Third-line therapy and beyond for patients with advanced/metastatic non-small cell lung cancer (NSCLC).

被引：0
|
作者：
Corral Jaime, Jesus [1 ]
Gonzalez de la Pena, Miriam [1 ]
Alonso, Miriam [1 ]
Sanchez Gastaldo, Amparo [1 ]
Dolores Mediano, Maria [1 ]
Amerigo, Marta [1 ]
Enrique Robles, Carlos [1 ]
机构：
[1] Hosp Univ Virgen Rocio, Seville, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19160
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Third-line chemotherapy in advanced non-small cell lung cancer: identifying the candidates in routine practice
    Girard, Nicolas
    Jacoulet, Pascale
    Gainet, Marie
    Elleuch, Rami
    Pernet, Didier
    Depierre, Alain
    Dalphin, Jean-Charles
    Westeel, Virginie
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S680 - S680
  • [22] Second- and third-line treatments in non-small cell lung cancer
    Kumar A.
    Wakelee H.
    Current Treatment Options in Oncology, 2006, 7 (1) : 37 - 49
  • [23] Third-Line Chemotherapy in Advanced Non-small Cell Lung Cancer: Identifying the Candidates for Routine Practice
    Girard, Nicolas
    Jacoulet, Pascale
    Gainet, Marie
    Elleuch, Rami
    Pernet, Didier
    Depierre, Alain
    Dalphin, Jean-Charles
    Westeel, Virginie
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (12) : 1544 - 1549
  • [24] Third Line Therapy in EGFR Positive Advanced Non-Small Cell Lung Cancer
    Pande, Nikhil
    Joshi, Amit
    Noronha, Vanita
    Patil, Vijay
    Chougule, Anuradha
    Janu, Amit
    More, Sucheta
    Goud, Supriya
    Karpe, Ashay
    Ramaswamy, Anant
    Chandrasekharan, Arun
    Talreja, Vikas
    Goel, Alok
    Prabhash, Kumar
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1229 - S1230
  • [25] Weekly paclitaxel as second/third-line treatment in advanced non-small cell lung cancer patients: Efficacy and tolerability
    Camps, C
    Caballero, C
    Blasco, A
    Safont, MJ
    Berrocal, A
    Garde, J
    Juarez, A
    Sirera, R
    Bremnes, RM
    ANTICANCER RESEARCH, 2005, 25 (6C) : 4611 - 4614
  • [26] The efficacy of anlotinib in squamous cell carcinoma (SCC) patients with or without hypertension in ALTER0303: Anlotinib as a third-line therapy in patients with advanced non-small cell lung cancer (NSCLC).
    Shi, Jianhua
    Han, Baohui
    Li, Kai
    Wang, Qiming
    Zhang, Li
    Wang Zhe-Hai
    Cheng, Ying
    He, Jianxing
    Shi, Yuankai
    Chen, Weiqiang
    Luo, Yi
    Wu, Lin
    Wang, Xiuwen
    Nan, Kejun
    Jin, Faguang
    Dong, Jian
    Li, Baolan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non-Small-Cell Lung Cancer
    Papadimitrakopoulou, Vassiliki A.
    Soria, Jean-Charles
    Jappe, Annette
    Jehl, Valentine
    Klimovsky, Judith
    Johnson, Bruce E.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (10) : 1594 - 1601
  • [28] Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study
    Hoang, Tien
    Campbell, Toby C.
    Zhang, Chong
    Kim, KyungMann
    Kolesar, Jill M.
    Oettel, Kurt R.
    Blank, Jules H.
    Robinson, Emily G.
    Ahuja, Harish G.
    Kirschling, Ron J.
    Johnson, Peter H.
    Huie, Michael S.
    Wims, Mary E.
    Larson, Martha M.
    Hernan, Hilary R.
    Traynor, Anne M.
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (01) : 195 - 199
  • [29] Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study
    Tien Hoang
    Toby C. Campbell
    Chong Zhang
    KyungMann Kim
    Jill M. Kolesar
    Kurt R. Oettel
    Jules H. Blank
    Emily G. Robinson
    Harish G. Ahuja
    Ron J. Kirschling
    Peter H. Johnson
    Michael S. Huie
    Mary E. Wims
    Martha M. Larson
    Hilary R. Hernan
    Anne M. Traynor
    Investigational New Drugs, 2014, 32 : 195 - 199
  • [30] Comorbidity in clinical trial patients with advanced or metastatic non-small cell lung cancer (NSCLC).
    Kosov, Maxim
    Kumar, Akhil
    Belotserkovskiy, Maxim
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345